CNXC Quote, Financials, Valuation and Earnings

DoubleVerify Holdings has a net margin of 2.81% compared to Concentrix's net margin of 10.74%. Concentrix's return on equity of 7.36% beat DoubleVerify Holdings's return on equity of 6.09%.

Concentrix has a consensus price target of --, signalling upside risk potential of 70.93%. On the other hand DoubleVerify Holdings has an analysts' consensus of $22.70 which suggests that it could grow by 14.88%. Given that Concentrix has higher upside potential than DoubleVerify Holdings, analysts believe Concentrix is more attractive than DoubleVerify Holdings.

Concentrix has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DoubleVerify Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Concentrix has a quarterly dividend of $0.33 per share corresponding to a yield of 2.88%. DoubleVerify Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Concentrix pays 20.23% of its earnings as a dividend. DoubleVerify Holdings pays out -- of its earnings as a dividend. Concentrix's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Concentrix quarterly revenues are $2.4B, which are larger than DoubleVerify Holdings quarterly revenues of $169.6M. Concentrix's net income of $66.8M is higher than DoubleVerify Holdings's net income of $18.2M. Notably, Concentrix's price-to-earnings ratio is 13.96x while DoubleVerify Holdings's PE ratio is 53.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentrix is 0.29x versus 5.43x for DoubleVerify Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Intellinetics has a net margin of 2.81% compared to Concentrix's net margin of -8.56%. Concentrix's return on equity of 7.36% beat Intellinetics's return on equity of -4.31%.

Concentrix has a consensus price target of --, signalling upside risk potential of 70.93%. On the other hand Intellinetics has an analysts' consensus of $11.85 which suggests that it could grow by 37.53%. Given that Concentrix has higher upside potential than Intellinetics, analysts believe Concentrix is more attractive than Intellinetics.

Concentrix has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Intellinetics has a beta of 0.468, suggesting its less volatile than the S&P 500 by 53.162%.

Concentrix has a quarterly dividend of $0.33 per share corresponding to a yield of 2.88%. Intellinetics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Concentrix pays 20.23% of its earnings as a dividend. Intellinetics pays out -- of its earnings as a dividend. Concentrix's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Concentrix quarterly revenues are $2.4B, which are larger than Intellinetics quarterly revenues of $4.6M. Concentrix's net income of $66.8M is higher than Intellinetics's net income of -$392.9K. Notably, Concentrix's price-to-earnings ratio is 13.96x while Intellinetics's PE ratio is 227.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentrix is 0.29x versus 3.56x for Intellinetics. Usually stocks with elevated PS ratios are considered overvalued.

UiPath has a net margin of 2.81% compared to Concentrix's net margin of -3%. Concentrix's return on equity of 7.36% beat UiPath's return on equity of -4.78%.

Concentrix has a consensus price target of --, signalling upside risk potential of 70.93%. On the other hand UiPath has an analysts' consensus of $15.18 which suggests that it could grow by 19.78%. Given that Concentrix has higher upside potential than UiPath, analysts believe Concentrix is more attractive than UiPath.

Concentrix has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison UiPath has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Concentrix has a quarterly dividend of $0.33 per share corresponding to a yield of 2.88%. UiPath offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Concentrix pays 20.23% of its earnings as a dividend. UiPath pays out -- of its earnings as a dividend. Concentrix's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Concentrix quarterly revenues are $2.4B, which are larger than UiPath quarterly revenues of $354.7M. Concentrix's net income of $66.8M is higher than UiPath's net income of -$10.7M. Notably, Concentrix's price-to-earnings ratio is 13.96x while UiPath's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentrix is 0.29x versus 5.25x for UiPath. Usually stocks with elevated PS ratios are considered overvalued.

WidePoint has a net margin of 2.81% compared to Concentrix's net margin of -1.23%. Concentrix's return on equity of 7.36% beat WidePoint's return on equity of -20.12%.

Concentrix has a consensus price target of --, signalling upside risk potential of 70.93%. On the other hand WidePoint has an analysts' consensus of -- which suggests that it could grow by 46.4%. Given that Concentrix has higher upside potential than WidePoint, analysts believe Concentrix is more attractive than WidePoint.

Concentrix has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison WidePoint has a beta of 1.716, suggesting its more volatile than the S&P 500 by 71.645%.

Concentrix has a quarterly dividend of $0.33 per share corresponding to a yield of 2.88%. WidePoint offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Concentrix pays 20.23% of its earnings as a dividend. WidePoint pays out -- of its earnings as a dividend. Concentrix's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Concentrix quarterly revenues are $2.4B, which are larger than WidePoint quarterly revenues of $34.6M. Concentrix's net income of $66.8M is higher than WidePoint's net income of -$425.2K. Notably, Concentrix's price-to-earnings ratio is 13.96x while WidePoint's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Concentrix is 0.29x versus 0.31x for WidePoint. Usually stocks with elevated PS ratios are considered overvalued.